Pharmocotherapy Principles and Practice- Lung Cancer

Contact Hours: 1.5

ACPE No: 014-999-07-102-H04

Activity Type:

Release Date:
Expiration Date:

Learning Objectives

Upon completion of this activity the participant should be able to:
On completion of the chapter, the reader will be able to
1. Identify major risk factors for the development of lung cancer.
2. Explain the pathologic progression of lung cancer and its relationship with signs and symptoms of the disease.
3. Make appropriate recommendations for screening or preventative measures in high-risk patients.
4. Understand staging of lung cancer patients and how it influences treatment decisions.
5. List the rationale, advantages, disadvantages, and place in therapy for adjuvant and neoadjuvant chemotherapy
6. Identify the chemotherapeutic regimens of choice for limited and extensive small cell lung carcinoma, as well as local, locally advanced, and advanced non–small cell lung carcinoma.
7. Monitor patients for chemotherapy-associated toxicity, and recommend appropriate management.
8. Distinguish the treatment goals of palliative care versus those of first-line treatment.

Faculty:

Computer Requirements for Online Courses
PC


MAC

Acpelogo The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.